Process to access Landscape Survey
NCI and the NCI Community Oncology Research Network (NCORP) developed the Landscape survey primarily to inform CCDR trial design and to aid in targeted site recruitment for study/trial participation. Stakeholders witnessed an increase in requests to access and utilize the landscape data for publication, independent of NCORP trial development. Consequently, NCI created an approval process for data requests with the goal of publication. First, investigators must request approval by their affiliated NCORP Research Base (RB).Per NCI, RB Statistics and Data Management Center (SDMC) are solely responsible for the landscape survey data and cannot disseminate any data. Consequently, the RB SDMC will perform all data analyses within the respective research base infrastructure. This document outlines NRG Oncology’s NCORP approval process to access landscape survey data for potential publication. Please note that this process is only if the landscape survey data will be published. The table below outlines the scenarios when an application must be submitted for approval.
| Concept development / Trial design | Publication | Approval of landscape survey access application required |
|---|---|---|
| Yes | Yes | Yes |
| Yes | No | No |
| No | Yes | Yes |
- Investigators must complete an application outlining the objectives, study rationale, and survey items requiring analysis. Investigators must submit this request to NRG’s NCORP Administrator, Erica Field (fielde@nrgoncology.org). Note: Investigators must be affiliated with an NCORP site or a member of an NRG NCORP committee.
- NRG Oncology CCDR chair and vice-chair, and the Deputy Director of NRG NCORP SDMC will review each request.
- The NRG NCORP Administrator will notify investigators of NRG’s decision via e-mail within 8 weeks of submission.
- Any approved project requires the investigator to subsequently submit their request for the NCI’s Landscape Survey Committee approval via Wake Forest link. Authorline requirements will be stated in the approval letter from NRG.
- Notification letters will articulate the rationale for any disapproval. The requesting investigator may use this information to resubmit an application after addressing the provided concerns.
- NCI’s Landscape Survey Committee will notify both the requesting investigator and NRG NCORP of the decision.
- If approved, NRG SDMC will prioritize the analysis within their workload. Highest priority is given to approved requests related to a concept. NRG Publications guidelines must be followed for all abstracts/presentations and manuscripts.
Top Heading
Scientific Program Non-Disease Site Scientific Committees Cancer Care Delivery Research Process to access Landscape Survey- Current Openings
-
NRG NCORP
- Cancer Care Delivery Research
- Cancer Prevention & Control
- Health Care Access Committee
- Patient Centered Outcomes Research
- Principal Investigators
- Advisory and Oversight Committees
- NCORP Resources
- Clinical Trials
- NRG Oncology Health Care Access Fellowship
-
Research Oversight Committees
- Executive Committee
- Research Strategy
- Protocol Operations Management
- Data Monitoring Committee
- Early Phase Trial Oversight Committee
-
Disease Site Committees
- Brain Tumor
- Breast Cancer
- Gastrointestinal Cancer
- Genitourinary Cancer Committee
-
Gynecologic Cancer
- Cervix/Vulva Cancer Subcommittee
- Ovarian Cancer Subcommittee
- Rare Tumor Subcommittee
- Uterine Corpus Cancer Subcommittee
- Head and Neck Cancer
- Lung Cancer
-
Non-Disease Site Scientific Committees
- Cancer Prevention & Control
-
Developmental Therapeutics
- Developmental Therapeutics RT Subcommittee
- Developmental Therapeutics Gynecologic Phase I Subcommittee
- Sarcoma Subcommittee
- Patient Centered Outcomes Research
- Translational Science
- Cancer Care Delivery Research
-
Scientific Core Committees
-
Medical Oncology Committee
- Pathology Committee
-
Protocol Support Committee
- CRA Subcommittee
- CTN Subcommittee
- Education & Training Subcommittee
- Mentorship Subcommittee
- Protocol Review Subcommittee
- Quality Control & Communication Subcommittee
- Protocol Support Committee – Discuss With Us
-
Radiation Oncology Committee
-
Health Care Access Committee
- Surgical Oncology Committee
-
Imaging Committee
-
Medical Oncology Committee
-
Administrative Committees
- Ancillary Projects Committee
- Communications
-
Investigator & Career Development (ICD) Committee
-
Membership
- Canadian Members Subcommittee
- International Members Subcommittee
- Veterans Affairs/Military Treatment Facility (VA-MTF) Subcommittee
- Patient Advocate Committee
- Publications
Stay current with science. Sign up for our newsletter.
Support NRG Oncology.
Help Our Cause.
We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More